Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Branded Legacy Inc

Healthcare US BLEG

0.04USD
-34699.96(100.00%)

Last update at 2026-06-02T13:30:00Z

Day Range

0.030.08
LowHigh

52 Week Range

0.00010.0012
LowHigh

Fundamentals

  • Previous Close 34700.00
  • Market Cap0.25M
  • Volume7866
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.27456M
  • Revenue TTM0.09M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.02M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.10843M 3.83M -0.16370M -0.31380M -0.29846M
Minority interest - - - - -
Net income -0.10843M 3.83M -0.16370M -0.31380M -0.29846M
Selling general administrative - - - 0.25M 0.24M
Selling and marketing expenses - - - 0.09M 0.08M
Gross profit 0.03M 0.08M 0.14M 0.03M 0.02M
Reconciled depreciation - - - 0.00000M 0.00361M
Ebit - 3.66M -0.16370M - -0.29846M
Ebitda -0.10843M 3.83M -0.14307M -0.31380M -0.29485M
Depreciation and amortization - 0.17M 0.02M - 0.00361M
Non operating income net other - - - - -
Operating income -0.10843M 3.83M -0.16370M -0.31380M -0.29846M
Other operating expenses 0.16M 3.74M 0.38M 0.38M 0.40M
Interest expense - - - 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.16789M -0.00001M - -
Total revenue 0.05M 0.08M 0.22M 0.06M 0.10M
Total operating expenses 0.14M -3.74288M 0.31M 0.34M 0.32M
Cost of revenue 0.02M 0.00026M 0.07M 0.03M 0.08M
Total other income expense net 0.00000M -0.00000M -0.00000M - -
Discontinued operations - - - - -
Net income from continuing ops - - - -0.31380M -0.29846M
Net income applicable to common shares - - - - -0.29846M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 3.34M 0.19M 0.16M 0.12M 0.15M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 1.55M 1.59M 1.74M 1.99M 1.70M
Total stockholder equity 1.79M -1.39662M -1.57834M -1.87109M -1.54867M
Deferred long term liab - - - - -
Other current liab 0.00712M 0.00662M - - 0.00063M
Common stock 0.61M 0.25M 0.03M 0.01M 0.00617M
Capital stock - - - 0.01M 0.00706M
Retained earnings -0.14723M 0.74M -0.16370M -3.16478M -2.83687M
Other liab - - - - 1.50M
Good will - - - - -
Other assets 0.00000M - 0.00000M - 0.00000M
Cash 0.00713M 0.00341M - 0.00142M 0.00580M
Cash and equivalents - - - - -
Total current liabilities 0.00749M 0.00717M 0.12M 0.07M 0.05M
Current deferred revenue - - - - 0.00063M
Net debt 1.53M 1.58M 0.12M 0.43M 0.15M
Short term debt - - 0.00254M 0.01M 0.00450M
Short long term debt - - - - -
Short long term debt total 1.54M 1.58M 0.12M 0.43M 0.16M
Other stockholder equity 0.27M 0.40M 1.72M 1.28M 1.28M
Property plant equipment - - - - 0.01M
Total current assets 0.26M 0.09M 0.16M 0.11M 0.14M
Long term investments - - - - -
Net tangible assets - - - - -1.54955M
Short term investments - - - - -
Net receivables 0.22M 0.01M 0.02M 0.02M 0.04M
Long term debt - - - 0.42M 0.15M
Inventory 0.03M 0.07M 0.14M 0.08M 0.09M
Accounts payable 0.00036M 0.00054M 0.12M 0.06M 0.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.05M -2.79324M -3.16444M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00000M 0.00000M - -
Deferred long term asset charges - - - - -
Non current assets total 3.08M 0.10M -0.00271M 0.01M 0.01M
Capital lease obligations - - - 0.01M 0.00450M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - -0.00949M 0.03M
Change to liabilities - - - - 0.02M
Total cashflows from investing activities 0.10M - - - 0.03M
Net borrowings - - - - -0.06570M
Total cash from financing activities 0.00970M -3.69073M -0.05203M 0.28M 0.27M
Change to operating activities - - - - 0.00005M
Net income -0.10843M 3.83M -0.16370M -0.31381M -0.29846M
Change in cash 0.00372M -0.00059M -0.00142M -0.00438M 0.00745M
Begin period cash flow 0.00341M 0.00400M 0.00142M 0.00580M -0.00165M
End period cash flow 0.00713M 0.00341M -0.00000M 0.00142M 0.00580M
Total cash from operating activities -0.10874M 3.69M 0.03M -0.26992M -0.29277M
Issuance of capital stock - - - 0.00549M 0.84M
Depreciation - - 0.02M 0.00000M 0.00361M
Other cashflows from investing activities - - - -0.00949M 0.00003M
Dividends paid - - - 0.27M 0.07M
Change to inventory - -0.03405M 0.14M 0.00577M -0.01974M
Change to account receivables - -0.00983M -0.02328M 0.02M 0.00182M
Sale purchase of stock - - - -0.00001M -0.50666M
Other cashflows from financing activities 0.00970M -4.34602M 0.02M 0.00003M -0.33222M
Change to netincome - - - - -0.01974M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.00031M -0.03626M 0.18M 0.04M 0.00208M
Stock based compensation - - - - -
Other non cash items - -0.09914M -0.13197M -0.03440M 0.00519M
Free cash flow -0.10874M 3.69M 0.03M -0.26992M -0.29277M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BLEG
Branded Legacy Inc		 -34699.96 100.00% 0.04 - - 2.84 471.32 103.34 -7.3983
ZTS
Zoetis Inc		 1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.58 1.91% 31.01 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc. was incorporated in 1981 and is headquartered in Melbourne, Florida.

Branded Legacy Inc

746 North Drive, Melbourne, FL, United States, 32934

Key Executives

Name Title Year Born
Mr. Jermain Strong CEO, CFO & Sec. 1985
Mr. Matthew Nichols VP NA
Mr. David Christopher Oswald CEO & Chairman NA
Mr. Phillip Michael White Chief Compliance Officer NA
Joseph Holladay C.O.O NA
Mr. Doug Holladay C.M.O NA
Dr. Jamie Forrest M.P.H., Ph.D. Interim Chief Executive Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions